Xarelto - Articles and news items

Blood clot deep vein thrombosis Venous thromboembolism pulmonary embolism

Venous thromboembolism (VTE) therapeutics market set to hit $3.7 billion by 2025

Industry news / 1 August 2016 / GlobalData

Growth will be driven by the uptake of novel oral anticoagulants, which represent important advances over warfarin, a cheap and established anticoagulant, says new report…

 

The deadline for submissions to the EPR Awards is 9 June 2017! Entry is FREE, so don't delay...
+